H.626

An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Sponsors: Rep. George Till

Location: House Committee on Health Care

Last Recorded Action: 1/10/2020 - Read First Time and Referred to the Committee on Health Care

Committee Activity - Meeting Full List

Regular Session 2019-2020

Friday, January 17, 2020

Committee(s):

House Committee on Health Care

-

H.626 - An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Rep. George W. Till, Sponsor

Thursday, January 30, 2020

Committee(s):

House Committee on Health Care

10:05 AM

H.626 - An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Rep. George W. Till, Sponsor
Jessica Chung, Resident from UVMMC